Currently, medications used to treat rheumatoid arthritis (RA) are glucocorticoids (GCs) and
nonsteroidal anti‐inflammatory drugs (NSAIDs), predominantly used for controlling the pain …

Methotrexate has been used in treatment of rheumatoid arthritis (RA) since the 1980s and to
this day is often the first line medication for RA treatment. In this review, we examine multiple …

Objective Although oral methotrexate (MTX) remains the anchor drug for rheumatoid arthritis
(RA), up to 50% of patients do not achieve a clinically adequate outcome. In addition, there …

Increased effectiveness of pharmacological treatments in early RA has led many to believe
that difficult-to-treat, established RA is a condition of the past. However, there are still plenty …

Psoriasis is a chronic inflammatory skin condition affecting diverse racial/ethnic groups
throughout the world. Large population-based studies suggest that psoriasis occurs most …

Methotrexate (MTX) is widely used and considered a first-line disease modifying anti-
rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Many of the relevant …

Methotrexate (MTX), a structural analog of folic acid, is widely employed in the treatment of
different cancers and autoimmune diseases. Despite the successful results observed, the …

Background: Methotrexate (MTX) is widely used and considered a first-line disease
modifying antirheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA) …

Rheumatoid arthritis (RA) is a common autoimmune inflammatory disease affecting 0.5–1%
of adults worldwide. Achieving long term remission or low disease activity is possible …

Rheumatoid arthritis (RA) is a chronic inflammatory disease that is very complex and
heterogeneous. If not adequately treated, RA patients are likely to manifest excess of …